Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • stocklooking stocklooking Mar 18, 2013 7:04 PM Flag

    NCI is lazy

    They just submitted a phase II trial for most thyroid cancers. Not started yet, plan to recruit only 25 subjects for so many stages and types at 9 sites. Will NCCN make compendium recommendations based on a small trial's result like that? Government guys, you know.

 
EXEL
3.15+0.01(+0.32%)May 22 3:59 PMEDT